RARA CRAFT DATABASE for FDA Medical Devices
PMAP180045

FDA DEVICE FACTS

LIAISON® XL MUREX HBc IgM, LIAISON® XL MUREX Control HBc IgM

DiaSorin, Inc.

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEAugust 29, 2020PRODUCT CODESEI

Indications for use

LIAISON® XL MUREX Anti-HBc IgM The LIAISON® XL MUREX HBc IgM assay is an in vitro chemiluminescent immunoassay (CLIA) for the qualitative detection of IgM anti-bodies to hepatitis B virus core antigen (HBc IgM) in human adult and pediatric (2 to 21 years) serum and plasma (lithium and sodium heparin, sodium citrate and K2 EDTA), including separator tubes, on the LIAISON® XL Analyzer. Assay results, in conjunction with other hepatitis B virus (HBV) serological markers and clinical information may be used as an aid in the diagnosis of HBV infection in patients with symptoms of hepatitis or who may be at risk for HBV infection. The presence of anti-HBc IgM is indicative of acute or recent HBV infection.

This assay is not approved for use in screening blood, plasma or tissue donors.

LIAISON® XL MUREX Control Anti-HBc IgM The LIAISON® XL MUREX Control HBc IgM (negative and positive) is intended for use as assayed quality control samples to monitor the performance of the LIAISON® XL MUREX HBc IgM assay. The performance characteristics of LIAISON® XL MUREX Control HBc IgM have not been established for any other assays or instrument platforms.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026